CD4 and Alzheimer disease: Recent results showed that the expression of these molecules is significantly reduced in AD and aMCI, thus, in these diseases, fewer PD-1-expressing CD4+ T cells bind reduced quantities of PD-L1 molecules on the surface of CD14+ APC.